XML 47 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Stock-based compensation        
Stock-based compensation expense $ 885,000 $ 858,000 $ 2,460,000 $ 2,313,000
Additional disclosure        
Total unrecognized compensation expense related to unvested stock-based awards 4,303,000   4,303,000  
Weighted average period over which expense is expected to be recognized     2 years 6 months 4 days  
Stock options
       
Weighted-average assumptions        
Risk-free interest rate (as a percent) 1.21% 1.47% 1.27% 2.01%
Expected volatility (as a percent) 63.14% 59.01% 70.44% 58.51%
Expected life 6 years 7 months 13 days 6 years 3 months 7 days 6 years 3 months 11 days 5 years 11 months 12 days
Estimated forfeiture rates (as a percent)     7.47% 7.89%
Options Outstanding        
Balance at the beginning of the period (in shares)     14,366,623  
Granted (in shares)     2,305,170  
Exercised (in shares)     (415,081)  
Forfeited (in shares)     (251,949)  
Expired (in shares)     (507,237)  
Balance at the end of the period (in shares) 15,497,526   15,497,526  
Vested or expected to vest at the end of the period (in shares) 14,882,686   14,882,686  
Exercisable at the end of the period (in shares) 10,447,411   10,447,411  
Weighted Average Exercise Price        
Balance at the beginning of the period (in dollars per share)     $ 3.83  
Granted (in dollars per share)     $ 1.85  
Exercised (in dollars per share)     $ 1.35  
Forfeited (in dollars per share)     $ 2.46  
Expired (in dollars per share)     $ 3.84  
Balance at the end of the period (in dollars per share) $ 3.62   $ 3.62  
Vested or expected to vest at the end of the period (in dollars per share) $ 3.62   $ 3.62  
Exercisable at the end of the period (in dollars per share) $ 3.78   $ 3.78  
Weighted Average Remaining Contractual Term        
Balance at the end of the period     5 years 10 months 2 days  
Vested or expected to vest at the end of the period     5 years 9 months 18 days  
Exercisable at the end of the period     5 years 1 month 20 days  
Aggregate Intrinsic Value        
Balance at the end of the period 10,796,300   10,796,300  
Vested or expected to vest at the end of the period 10,360,500   10,360,500  
Exercisable at the end of the period 6,473,900   6,473,900  
Additional disclosure        
Weighted-average grant-date fair value of options granted (in dollars per share)     $ 1.18  
Total intrinsic value of options exercised     528,000  
Cash received from exercise of options     $ 560,000  
Stock options | Minimum
       
Weighted-average assumptions        
Period over which stock is not traded in market     1 year  
Stock Option Plans
       
Stock-based compensation        
Number of shares authorized for issuance 24,000,976   24,000,976  
Stock Option Plans | Stock options
       
Stock-based compensation        
Expiration term of options granted     10 years  
Stock Option Plans | Stock options | Minimum
       
Stock-based compensation        
Options granted vesting period     4 years  
Stock Option Plans | Stock options | Maximum
       
Stock-based compensation        
Options granted vesting period     5 years  
Employee Stock Purchase Plan
       
Stock-based compensation        
Purchase price expressed as percentage of fair market value of common stock     85.00%